DOHA: Investcorp, a leading global provider and manager of alternative investment products, yesterday announced that it has signed an agreement to acquire a majority interest in Cambio Healthcare Systems AB (Cambio) from Valedo Partners Fund II AB (Valedo) and a group of minority investors. Cambio’s founders and management team will continue to hold a meaningful stake in the Company. The transaction remains subject to receipt of customary regulatory approvals.
Cambio operates in the Electronic Health Records (EHR) market, offering software solutions for acute, primary, social and person-centred care. Cambio promotes a holistic view on health and social care and offers an EHR agnostic solution for clinical decision support applicable for all branches of health and social care.
The Company, which has grown rapidly in recent years, has customers primarily in Sweden, Denmark and the United Kingdom, with more than 150,000 users of its software solutions. Cambio is headquartered in Stockholm, Sweden and has approximately 600 employees, of which the majority are dedicated to research and development as well as software maintenance.
Hazem Ben-Gacem, Co-CEO of Investcorp (pictured), said: “We see solid growth potential in Cambio Healthcare System, which has already established itself as a strong player in the European region, offering innovative solutions in a promising healthcare market. We look forward to working with Cambio’s management team and using our expertise to build on their success story.”
Peter Gille, CEO, Cambio Healthcare Systems, said; “eHealth is increasingly transforming how healthcare is delivered, and is a key enabler for further improvements of quality of care, productivity and patient empowerment. Cambio is clearly one of the leading providers in the Nordic and UK eHealth markets and I am very proud of our achievements during the last few years. We now look forward to continuing Cambio’s growth journey with the support of Investcorp.”
